Daniel Tatosian
About Daniel Tatosian
Daniel Tatosian is the Senior Director at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in Clinical Pharmacology and Pharmacometrics. He holds a Ph.D. in Chemical Engineering from Cornell University and has previously worked at Merck for 11 years.
Current Role at Bristol Myers Squibb
Daniel Tatosian currently holds the position of Senior Director at Bristol Myers Squibb in Summit, New Jersey, United States. In this role, he leverages his extensive expertise in clinical pharmacology and pharmacometrics to contribute to the company's projects and initiatives. He joined Bristol Myers Squibb in 2020 as Director, Clinical Pharmacology and Pharmacometrics, and was promoted to Senior Director after demonstrating considerable contributions in his field.
Previous Experience at Bristol Myers Squibb
Before becoming Senior Director, Daniel served as Director of Clinical Pharmacology and Pharmacometrics at Bristol Myers Squibb from 2020 to 2022. During his two-year tenure in this role based in Lawrence Township, NJ, he was responsible for key initiatives in clinical pharmacology which supported the company's drug development programs.
Tenure at Merck
Daniel Tatosian dedicated 11 years of his career to Merck, initially joining as an Associate Principal Scientist in 2009 and later becoming a Principal Scientist in 2014. In these roles based in Rahway, New Jersey, he made significant contributions to the company's scientific research and development efforts. His tenure at Merck provided him with a solid foundation and extensive experience in clinical pharmacology and pharmacometrics.
Educational Background in Chemical Engineering
Daniel Tatosian holds a Ph.D. in Chemical Engineering from Cornell University, where he studied from 2001 to 2007. He also earned a Bachelor's degree in Chemical Engineering from the University of Massachusetts Amherst, which he completed in 2001. His strong educational background in chemical engineering has been fundamental in shaping his career in the pharmaceutical industry.